NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING THE UNITED STATES) WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION..
23 November 2020
Sativa Wellness Group Inc.
(“Sativa Wellness” or the “Company”)
EU courts clear the way for CBD in Europe
The European Union’s highest court has ruled that CBD (Cannabidiol) is not a narcotic drug, and that a French ban on hemp derived CBD contradicts EU law.
This ruling has opened the door for high quality compliant CBD companies to operate in markets across the EU.
The Sativa Wellness Group Inc. welcomes this news as the company operates CBD extraction and production facilities in the UK and Europe.
The Group have embraced the industry regulations in the UK and are on track to have its Novel Food dossier, incorporating an extensive product range, validated by the UK FSA ahead of the March 2021. Following the ECJ ruling, the Company believes that the European FSA will resume their Novel Food process, and intend to submit their application to the EU FSA in parallel to the UK process.
The Sativa Wellness Group Inc. holds a unique ‘seed to consumer’ position in the market, offering consistent quality control of the cannabinoid, full traceability of ingredients, manufacturing and testing with the added reassurance to the customer that each batch is QR coded which tracks back to its testing report.
From this enviable position the Sativa Wellness Group Inc. have developed the ‘Goodbody’ brand- CBD you can trust. Under the brand umbrella are the Goodbody Botanicals range for the everyday and pharmaceutical markets and the Goodbody Wellness brand, with its addition of Vitamin D, as a premium CBD brand for the health and beauty spa market.
The Goodbody range is available at retailers and direct to the consumer online through Goodbodystore.com and soon available in Europe. As part of our route to market we intend to focus on retail listings and selling directly online within Europe.
“We welcome the news of the EUs highest court ruling. As a UK and European company that is committed to working with regulators and delivering the highest quality CBD wellness products, this news helps to enable our expansion plans. We currently own extraction and production capabilities in Europe and see this large market as a key driver for our growth for not only our CBD isolate and distillate ingredients, but also for our Goodbody CBD brands!“ said Henry Lees-Buckley, CEO of the Sativa Wellness Group Inc.